Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Study of Xaciato in Healthy Women
NCT05354050Phase 1Completed
- Sponsor
- Daré Bioscience, Inc.
- Start
- Nov 2020
- Primary completion
- Nov 2020
- Modality
- Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of DARE-BV1 in bacterial vaginosis (BV), sponsored by Daré Bioscience, Inc. Primary endpoint: Pharmacokinetics at 7 days. Started Nov 2020; status: completed.
02
Drugs
DARE-BV1
03
Conditions
bacterial vaginosis (BV)
Beyond the preview
Go deeper on NCT05354050.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05354050.